BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
Cipla Stake Sale Plan Faces Indecision Amidst Valuation Disagreements October 10, 2023 The ongoing buzz surrounding the Cipla acquisition has taken a new turn, with promoters disagreements on the company's valuation figure.
Sai Life Sciences Teams Up with Dassault Systèmes' to Boost Drug Discovery Efforts October 9, 2023 Sai Life Sciences, a contract research, development, and manufacturing organisation has joined forces with Dassault Systèmes', a global leader in 3D design, engineering, and software solutions, to accelerate its drug discovery endeavours.
WiStride Launches its Intelligence-Powered B2B App October 9, 2023 WiStride, India's first-ever intelligence-powered integrated B2B platform for active pharmaceutical ingredients (APIs), intermediates and raw materials, has launched its digital platform.
Kotak Fund to Invest INR 1,600 Cr in Nimmagadda Prasad's API Biz October 9, 2023 India's Kotak Mahindra Group asset management arm, Kotak Strategic Situations Fund (KSSF) has planned to invest around INR 1,600 Cr in the recently acquired active pharmaceutical ingredients (API) business by Nimmagadda Prasad, from Viatris last week.
AstraZeneca India gets CDSCO Marketing Approval for Palivizumab, a Preventive Therapy for RSV October 4, 2023 AstraZeneca Pharma India, a leading biopharmaceutical company has received marketing approval from the Central Drugs Standard Control Organisation (CDSCO) to import and distribute €˜Palivizumab injection 100 mg/ml (r-DNA origin) in India.
Centre Approves INR 6,000 Cr Investment for Pharma & Medical Devices under PLI Scheme: Amit Shah October 3, 2023 This investment aims to foster the production of APIs and KSMs, essential components in drug and medical device manufacturing, as part of the government's holistic approach to cultivate a robust ecosystem for the domestic production of these vital healthcare components.
Pharma Czar Nimagadda aka 'Matrix' Prasad-Backed IQuest Enterprises Acquires Viatris' Indian API Biz October 3, 2023 IQuest Enterprises, a Hyderabad-based investment firm, promoted by Nimmagadda Prasad, has entered into a definitive agreement to acquire the active pharmaceutical ingredients (API) business of global pharmaceutical major Viatris in India.
Healthtech Startup Superceuticals Launches Instant Biochemical and Biophysical Analyser SC-AN 2.4 September 29, 2023 A standout feature is its capacity to generate instant reports, delivering results in just 10 minutes, thus ensuring rapid and efficient patient care. Driven by advanced technology, it surpasses traditional diagnostics by incorporating digital health records to elevate the overall patient experience.
Cipla is in Advanced Talks with Companies to Sell 60% Stake September 29, 2023 Following a series of collaborative efforts and funding preparation to acquire Cipla, the country's third-largest drugmaker has finally come to the field. It's now in discussion with two consortiums to sell a controlling 60% stake.
Cipla Joins Hands with Skye Air Mobility to Offer Drone-Powered Medicine Delivery in HP September 27, 2023 The primary goal is to ensure prompt delivery of medications to pharmacies and clinics in remote regions while minimising the potential risks associated with temperature fluctuations that could affect cold chain products.
IISER Bhopal Scientists Identify Key RNA in HIV-1 Multiplication September 27, 2023 Led by Dr Ajit Chande from the department of biological sciences at IISER Bhopal, the research underscores how ciTRAN facilitates the copying of genetic information from the virus, aiding the virus in multiplying more effectively.
Lilavati Hospital Ventures Into Pharmacy Biz, to Open 500 Stores within 5 Yrs September 27, 2023 Promoter of the Lilavati Hospital, has unveiled Lilavati Pharmacy in Ahmedabad. This move aligns with their objective of establishing a chain of Lilavati Pharmacy stores across the country.
